Bayesian Capital Management, LP

Position in EW — Edwards Lifesciences Corp

CIK 1632551 Brooklyn, NY

Position in EW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$566,726

-$2,707,391 QoQ

Shares Held

7,077

-83.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bayesian Capital Management, LP holds $2,099,387 across 2 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)	Open
1	BSX	Boston Scientific Corp	48,500	$2,069,980
2	CERS	Cerus Corp	10,071	$29,407

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$566,726	7,077	-83.2%	Shares	Sole	2026-05-15
2025-09-30	$3,274,117	42,100	+679.8%	Shares	Sole	2025-11-14
2022-03-31	$635,570	5,399	-73.8%	Shares	Sole	2022-05-16
2020-12-31	$1,879,338	20,600	-29.5%	Shares	Sole	2021-02-12
2020-09-30	$2,330,744	29,200	+48.2%	Shares	Sole	2020-11-12
2020-06-30	$1,361,467	19,700	+535.5%	Shares	Sole	2020-08-14
2020-03-31	$584,721	3,100	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.